ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs

June 28, 1996

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978

Coordination, Funding Lacking In National Cancer Program: Report

October 7, 1994

BRMP Investigators Find New Lung Tumor Antigen, Seek Developers

January 8, 1982

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

WHT Participants Get “Phase Out” Help

March 11, 1988